Single-dose pharmacokinetics of aztreonam in pediatric patients.
Single intravenous doses (30 mg/kg) of aztreonam, a novel monobactam antibiotic, were administered to 29 children from 2 days to 11 years old. Serum, urine, and, when possible, cerebrospinal fluid samples were analyzed by high-pressure liquid chromatography and microbiological methods. The concentra...
保存先:
| 出版年: | Antimicrob Agents Chemother |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
1984
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284118/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6541452/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.26.2.196 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|